These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 20127713

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of glycogen synthase kinase-3 in androgen-responsive prostate cancer cell lines: are GSK inhibitors therapeutically useful?
    Rinnab L, Schütz SV, Diesch J, Schmid E, Küfer R, Hautmann RE, Spindler KD, Cronauer MV.
    Neoplasia; 2008 Jun; 10(6):624-34. PubMed ID: 18516299
    [Abstract] [Full Text] [Related]

  • 5. Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.
    Rivest P, Renaud M, Sanderson JT.
    Chem Biol Interact; 2011 Feb 01; 189(3):177-85. PubMed ID: 21111724
    [Abstract] [Full Text] [Related]

  • 6. GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma.
    Dal Col J, Dolcetti R.
    Cell Cycle; 2008 Sep 15; 7(18):2813-6. PubMed ID: 18769147
    [Abstract] [Full Text] [Related]

  • 7. PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer.
    Gravina GL, Marampon F, Muzi P, Mancini A, Piccolella M, Negri-Cesi P, Motta M, Lenzi A, Di Cesare E, Tombolini V, Jannini EA, Festuccia C.
    Endocr Relat Cancer; 2013 Jun 15; 20(3):321-37. PubMed ID: 23507703
    [Abstract] [Full Text] [Related]

  • 8. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
    Li Y, Wang Z, Kong D, Li R, Sarkar SH, Sarkar FH.
    J Biol Chem; 2008 Oct 10; 283(41):27707-27716. PubMed ID: 18687691
    [Abstract] [Full Text] [Related]

  • 9. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B, Johnson JN, Ross RS, Singh M, Singh K.
    J Mol Cell Cardiol; 2007 Mar 10; 42(3):653-61. PubMed ID: 17292911
    [Abstract] [Full Text] [Related]

  • 10. GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells.
    Sun A, Li C, Chen R, Huang Y, Chen Q, Cui X, Liu H, Thrasher JB, Li B.
    Prostate; 2016 Feb 10; 76(2):172-83. PubMed ID: 26440826
    [Abstract] [Full Text] [Related]

  • 11. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
    Terry S, Yang X, Chen MW, Vacherot F, Buttyan R.
    J Cell Biochem; 2006 Oct 01; 99(2):402-10. PubMed ID: 16741972
    [Abstract] [Full Text] [Related]

  • 12. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
    Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GP, Sarkar FH.
    J Biol Chem; 2007 Jul 20; 282(29):21542-50. PubMed ID: 17522055
    [Abstract] [Full Text] [Related]

  • 13. Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.
    Liu S, Vinall RL, Tepper C, Shi XB, Xue LR, Ma AH, Wang LY, Fitzgerald LD, Wu Z, Gandour-Edwards R, deVere White RW, Kung HJ.
    Oncogene; 2008 Jan 17; 27(4):499-505. PubMed ID: 17653089
    [Abstract] [Full Text] [Related]

  • 14. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 15. Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
    Darrington RS, Campa VM, Walker MM, Bengoa-Vergniory N, Gorrono-Etxebarria I, Uysal-Onganer P, Kawano Y, Waxman J, Kypta RM.
    Int J Cancer; 2012 Sep 15; 131(6):E872-83. PubMed ID: 22539113
    [Abstract] [Full Text] [Related]

  • 16. Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: regulation of PTH1R nuclear-cytoplasmic shuttling by importin-alpha/beta and chromosomal region maintenance 1/exportin 1.
    Pickard BW, Hodsman AB, Fraher LJ, Watson PH.
    Endocrinology; 2007 May 15; 148(5):2282-9. PubMed ID: 17317770
    [Abstract] [Full Text] [Related]

  • 17. The Cellular Distribution of RanGAP1 Is Regulated by CRM1-Mediated Nuclear Export in Mammalian Cells.
    Cha K, Sen P, Raghunayakula S, Zhang XD.
    PLoS One; 2015 May 15; 10(10):e0141309. PubMed ID: 26506250
    [Abstract] [Full Text] [Related]

  • 18. CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA.
    Kimura T, Hashimoto I, Nagase T, Fujisawa J.
    J Cell Sci; 2004 May 01; 117(Pt 11):2259-70. PubMed ID: 15126627
    [Abstract] [Full Text] [Related]

  • 19. 6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.
    Zhang X, Castanotto D, Nam S, Horne D, Stein C.
    Mol Ther; 2017 Jan 04; 25(1):79-91. PubMed ID: 28129131
    [Abstract] [Full Text] [Related]

  • 20. Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms.
    Meissner T, Krause E, Vinkemeier U.
    FEBS Lett; 2004 Oct 08; 576(1-2):27-30. PubMed ID: 15474004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.